Earnings report 📈 Stocks 🌍 United States

Evolv Technologies Q3 Revenue Hits $47M as Full-Year Guidance Tightens

Evolv Technologies posted mixed Q3 2026 results with revenue growth and positive free cash flow offset by a widened net loss of $(15,564) thousand and increased operating costs.

🕐 1 min read

1 assets impacted (Stocks). Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: EVLV → 4/10 (55% confidence).

📊 Affected Assets (1)

EVLV
Neutral 🤖 55%
📅 Short-term 🌍 US · Explicit

Q3 2026 revenue rose to $47,345 thousand from $42,850 thousand and the company nudged full-year revenue guidance to $182-$185 million while lifting Adjusted EBITDA guidance to $15.5-$16.5 million from $15-$16 million. However, the quarterly net loss widened to $(15,564) thousand from $(1,796) thousand on sharply higher operating expenses. The modest guidance raise and first positive free cash flow offset the wider loss, leaving the overall picture mixed.

Catalysts
  • • Full-year 2026 Adjusted EBITDA guidance raised to $15.5-$16.5 million from $15-$16 million (issued November 10, 2026)
  • • Q3 2026 free cash flow of $3,247 thousand versus $(11,485) thousand a year earlier
Risk Factors
  • • Net loss widened to $(15,564) thousand from $(1,796) thousand in Q3 2026
  • • General and administrative expenses jumped to $18,657 thousand from $12,579 thousand year over year

🧭 Full analysis of these assets

🎯 Key Takeaways

  • Q3 2026 revenue rose to $47,345 thousand from $42,850 thousand in the same period last year.
  • Full-year 2026 Adjusted EBITDA guidance was raised to $15.5-$16.5 million from the previous $15-$16 million range.
  • Quarterly net loss widened to $(15,564) thousand compared to $(1,796) thousand in Q3 2025.
  • Annual recurring revenue grew to $140,510 thousand as of September 30, 2026, up from $120,467 thousand a year earlier.
  • The company achieved positive free cash flow of $3,247 thousand in Q3 2026, compared to $(11,485) thousand in Q3 2025.

📝 Executive Summary

Evolv Technologies reported Q3 2026 revenue of $47,345 thousand, up from $42,850 thousand in the prior year. While the company achieved its first positive quarterly free cash flow of $3,247 thousand, net losses widened to $(15,564) thousand due to rising operating expenses. Management raised its full-year 2026 Adjusted EBITDA guidance to $15.5-$16.5 million.

❓ FAQ

Did Evolv raise its 2026 outlook?

Yes, slightly. Full-year revenue guidance was tightened to $182-$185 million (from $180-$185 million) and Adjusted EBITDA guidance was raised to $15.5-$16.5 million (from $15-$16 million), with the ending ARR target of $148-$150 million unchanged.

Is the company profitable?

No. It reported a net loss of $(15,564) thousand for the third quarter of 2026, wider than $(1,796) thousand a year ago, though quarterly free cash flow turned positive at $3,247 thousand.